Skip to Main Content

Paper Details

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program.
Ann Epidemiol
12
2023
Author NameAffiliation
Yonathan BrhaneLunenfeld-Tanenbaum Research Institute
Demetrius AlbanesNational Cancer Institute
Christine D Berg
Qiuyin CaiVanderbilt University Medical Center
John K FieldMolecular & Clinical Cancer Medicine, University of Liverpool
Geoffrey LiuPrincess Margaret Cancer Center
Roger L MilneUniversity of Melbourne, Australia School of Clinical Sciences at Monash Health, Monash University
Thomas E RohanAlbert Einstein College of Medicine
Xiao-Ou ShuVanderbilt University Medical Center
Lesley F TinkerWomen's Health Initiative Clinical Coordinating Center, Fred Hutchinson Cancer Research Center
Stephanie J WeinsteinNational Cancer Institute
Wei ZhengVanderbilt University Medical Center
Christopher I AmosInstitute for Clinical and Translational Research, Baylor College of Medicine
Christopher I AmosInstitute for Clinical and Translational Research, Baylor College of Medicine
Rayjean J HungLunenfeld-Tanenbaum Research Institute, Canada Dalla Lana School of Public Health, University of Toronto
  • 1 - 15

Datasets

Release 1.2